{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:19:18Z","timestamp":1787771958042,"version":"build-2784847793"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Topical steroid damaged face (TSDF) is a common occurrence in the current scenario, where darker - skinned people believe having lighter-colored skin improves their prospects in all aspects of life. This has led to the abuse of topical corticosteroids with unrealistic expectations driven by ignorance of the adverse effects, particularly in the Indian population. As TSDF is virtually an epidemic in India and there is no treatment protocol for dermatologists, we conducted this study to find out what dermatologists prescribe and, in turn, serve as a foundation to develop guidelines in the future.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Forty dermatologists from Odisha, India, were selected to complete the questionnaire, containing 18 questions about diagnosis, treatment and necessary referral for ocular complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>All participants were frequently diagnosing and treating TSDF. A total of 92.5% of the participants preferred initiating systemic therapy with isotretinoin or doxycycline as the drug of choice. Clindamycin and tacrolimus were preferred by 55% and 50% of participants, respectively, as the topical drug of choice. A total of 62.5% of the participants advised physical sunscreens and mild cleansers to be used with water at room temperature to wash their face. To reduce facial erythema, brimonidine was advised by 45% of participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Standardized guidelines for managing TSDF are the need of the hour.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/idoj.idoj_453_23","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T06:02:01Z","timestamp":1710396121000},"page":"247-251","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Prescribing Patterns in the Treatment of Topical Steroid Damaged Face Patients: A Cross-Sectional, Survey-Based Observational Study among Practicing Dermatologists in an Eastern State of India"],"prefix":"10.4103","volume":"15","author":[{"given":"Chinmoy","family":"Raj","sequence":"first","affiliation":[{"name":"Department of D.V.L., KIMS Hospital, KIIT University, Patia, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maitreyee","family":"Panda","sequence":"additional","affiliation":[{"name":"Department of D.V.L., IMS and SUM Hospital, SOA University, Kalinga Nagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhabani S. T. P.","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of D.V.L., IMS and SUM Hospital, SOA University, Kalinga Nagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash R.","family":"Kar","sequence":"additional","affiliation":[{"name":"Department of D.V.L., IMS and SUM Hospital, SOA University, Kalinga Nagar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nibedita","family":"Patro","sequence":"additional","affiliation":[{"name":"Department of D.V.L., Hi-Tech Medical College and Hospital, Pandra, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4103\/0019-5154.139872","article-title":"Topical steroid-damaged skin","volume":"59","author":"Abraham","year":"2014","journal-title":"Indian J Dermatol"},{"key":"R2-20240828","first-page":"20","article-title":"Management of papulopustular rosacea and perioral dermatitis with emphasis on iatrogenic causation or exacerbation of inflammatory facial dermatoses: Use of doxycycline-modified release 40mg capsule once daily in combination with properly selected skin care as an effective therapeutic approach","volume":"4","author":"Rosso","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/0019-5154.182417","article-title":"Topical steroid damaged\/dependent face (TSDF): An entity of cutaneous pharmacodependence","volume":"61","author":"Lahiri","year":"2016","journal-title":"Indian J Dermatol"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1468-3083.2008.02639.x","article-title":"Quality of life in patients with facial steroid dermatitis before and after treatment","volume":"22","author":"Liu","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/0378-6323.77455","article-title":"Topical corticosteroid abuse on the face: A prospective, multicenter study of dermatology outpatients","volume":"77","author":"Saraswat","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/idoj.IDOJ_535_15","article-title":"Misuse of topical corticosteroids over face: A clinical study","volume":"8","author":"Manchanda","year":"2017","journal-title":"Indian Dermatol Online J"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0738-081X(01)00244-9","article-title":"Demodex folliculorum in development of dermatitis rosaceiformis steroidica and rosacea-related diseases","volume":"20","author":"Basta-Juzbasi\u0107","year":"2002","journal-title":"Clin Dermatol"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/17469872.1.4.547","article-title":"The red skin syndromes: Corticosteroid addiction and withdrawal","volume":"1","author":"Rapaport","year":"2006","journal-title":"Expert Rev Dermatol"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/ijdd.ijdd_11_19","article-title":"Isotretinoin: In acne and beyond \u2013 An overview","volume":"6","author":"Bubna","year":"2020","journal-title":"Indian J Drugs Dermatol"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/0019-5154.97666","article-title":"Efficacy of 2% metronidazole gel in moderate acne vulgaris","volume":"57","author":"Khodaeiani","year":"2012","journal-title":"Indian J Dermatol"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"E1802","DOI":"10.1503\/cmaj.201085","article-title":"The efficacy and safety of sunscreen use for the prevention of skin cancer","volume":"192","author":"Sander","year":"2020","journal-title":"CMAJ"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/ced.12104","article-title":"Use of emollients in dry-skin conditions: Consensus statement","volume":"38","author":"Moncrieff","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/ijdd.ijdd_6_16","article-title":"Topical steroid-dependent face: Response to xylometazoline topical","volume":"3","author":"Kakkar","year":"2017","journal-title":"Indian J Drugs Dermatol"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/ajd.12292","article-title":"Ocular side-effects of topical corticosteroids: What a dermatologist needs to know","volume":"56","author":"Daniel","year":"2015","journal-title":"Australas J Dermatol"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_453_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:22:54Z","timestamp":1787768574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_453_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_453_23","relation":{},"ISSN":["2229-5178","2249-5673"],"issn-type":[{"value":"2229-5178","type":"print"},{"value":"2249-5673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]},"assertion":[{"value":"2023-06-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}